Litcius/Paper detail

Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response

Sangjoon Choi, Soo Ick Cho, Minuk Ma, Seonwook Park, Sérgio Pereira, Brian Jaehong Aum, Seunghwan Shin, Kyunghyun Paeng, Donggeun Yoo, Wonkyung Jung, Chan‐Young Ock, Se‐Hoon Lee, Yoon‐La Choi, Jin‐Haeng Chung, Tony Mok, Hyojin Kim, Seokhwi Kim

2022European Journal of Cancer61 citationsDOI

Topics & Concepts

AnalyserLung cancerMedicineImmunotherapyOncologyVariation (astronomy)Programmed cell death 1Internal medicineCancerPD-L1ChemistryPhysicsAstrophysicsChromatographyCancer Immunotherapy and BiomarkersAI in cancer detectionRadiomics and Machine Learning in Medical Imaging
Artificial intelligence–powered programmed death ligand 1 analyser reduces interobserver variation in tumour proportion score for non–small cell lung cancer with better prediction of immunotherapy response | Litcius